Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Control of HIV-1 replication by RNA interference.

Nan Sook Lee1, John J Rossi

  • 1Division of Molecular Biology, Beckman Research Institute of the City of Hope, Duarte, CA 91010, USA.

Virus Research
|April 8, 2004
PubMed
Summary

Small interfering RNAs (siRNAs) offer a gene-specific approach to inhibit gene expression and control HIV-1 replication. Further research is needed to address challenges for RNA interference (RNAi) therapy against HIV-1.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revisiting long-standing biological questions through evolving technologies.

Bioscience trends·2026
Same author

RNA activation as a precision dosing modality: MTL-CEBPA for controlled enzyme elevation in MPS I-H.

Frontiers in medicine·2026
Same author

Transcription Factor-Mediated Reprogramming of Cancer-Associated Fibroblasts Reveals Targetable Vulnerabilities in Solid Tumors.

bioRxiv : the preprint server for biology·2026
Same author

C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion.

Molecular therapy : the journal of the American Society of Gene Therapy·2025
Same author

Tumour priming by ultrasound mechanogenetics for CAR T therapy.

Nature materials·2025
Same author

ASOs reduce SARS-CoV-2 viral titers in Syrian golden hamsters.

Molecular therapy. Nucleic acids·2025

Area of Science:

  • Molecular Biology
  • Virology
  • Gene Therapy

Background:

  • Small interfering RNAs (siRNAs) induce sequence-specific gene silencing via RNA interference (RNAi) in mammalian cells.
  • RNAi targets messenger RNAs (mRNAs) for degradation at the post-transcriptional level, a mechanism known as post-transcriptional gene silencing (PTGS).
  • RNAi has demonstrated potential in inhibiting HIV-1 replication by targeting viral or cellular genes.

Purpose of the Study:

  • To review the current scientific understanding of RNA interference (RNAi) applications for controlling HIV-1 replication.
  • To assess the potential of RNAi as a gene therapy strategy for HIV-1.
  • To identify challenges and limitations for therapeutic applications of RNAi-mediated technologies against HIV-1.

Main Methods:

  • Review of existing scientific literature on RNA interference (RNAi) and its application to HIV-1.
  • Analysis of studies investigating the inhibition of HIV-1 replication using RNAi targeting viral and cellular genes.
  • Discussion of the complexities and potential hurdles in developing RNAi-based therapies for HIV-1.

Main Results:

  • RNA interference (RNAi) is an effective method for gene knockdown in mammalian cells.
  • RNAi has shown promise in inhibiting HIV-1 replication through targeted gene silencing.
  • HIV-1's rapid mutation rate and limitations of current therapies complicate RNAi-based treatment strategies.

Conclusions:

  • RNA interference (RNAi) presents a potential gene-specific therapeutic option for controlling HIV-1 replication.
  • Significant challenges remain in translating RNAi technologies into effective HIV-1 therapies.
  • Further assessment is crucial to overcome obstacles and realize the full therapeutic potential of RNAi for HIV-1.

Related Experiment Videos